Vesicare and Multiple sclerosis relapse - from FDA reports


Summary

Multiple sclerosis relapse is found among people who take Vesicare, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Ampyra, and have Multiple sclerosis. This review analyzes which people have Multiple sclerosis relapse with Vesicare. It is created by eHealthMe based on reports of 18,037 people who have side effects when taking Vesicare from FDA , and is updated regularly.

What to expect?

If you take Vesicare and have Multiple sclerosis relapse, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Vesicare and have Multiple sclerosis relapse

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Oct, 21, 2017

18,037 people reported to have side effects when taking Vesicare.
Among them, 224 people (1.24%) have Multiple sclerosis relapse


Number of reports submitted per year:

Could Vesicare cause Multiple sclerosis relapse?

Time on Vesicare when people have Multiple sclerosis relapse *:

  • < 1 month: 50 %
  • 1 - 6 months: 50 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Multiple sclerosis relapse when taking Vesicare *:

  • female: 85.65 %
  • male: 14.35 %

Age of people who have Multiple sclerosis relapse when taking Vesicare *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 1.09 %
  • 30-39: 8.74 %
  • 40-49: 27.32 %
  • 50-59: 38.8 %
  • 60+: 24.04 %

Top conditions involved for these people *:

  • Multiple Sclerosis (156 people, 69.64%)
  • Gait Disturbance (36 people, 16.07%)
  • Relapsing-Remitting Multiple Sclerosis (33 people, 14.73%)
  • Depression (14 people, 6.25%)
  • Stress And Anxiety (11 people, 4.91%)

Top co-used drugs for these people *:

  • Ampyra (79 people, 35.27%)
  • Gilenya (54 people, 24.11%)
  • Tysabri (47 people, 20.98%)
  • Vitamin D (41 people, 18.30%)
  • Baclofen (35 people, 15.62%)

Top other side effects for these people *:

  • Fatigue (53 people, 23.66%)
  • Gait Disturbance (50 people, 22.32%)
  • Weakness (43 people, 19.20%)
  • Fall (40 people, 17.86%)
  • Paraesthesia (32 people, 14.29%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Multiple sclerosis relapse when taking Vesicare?

Expand the study to include all drugs with the same ingredients

Multiple sclerosis relapse and drugs with ingredients of solifenacin succinate.

Expand the study to include reports from both FDA and eHealthMe

Multiple sclerosis relapse and Vesicare from FDA and eHealthMe reports

Vesicare

Vesicare has active ingredients of solifenacin succinate. It is often used in urge incontinence. (latest outcomes from Vesicare 18,751 users)

Multiple sclerosis relapse

Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath) has been reported by people with multiple sclerosis, relapsing-remitting multiple sclerosis, gait disturbance, depression, pain (latest reports from 45,135 Multiple sclerosis relapse patients).

Browse all side effects of Vesicare

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Multiple sclerosis relapse

Multiple sclerosis relapse

Could your condition cause Multiple sclerosis relapse

Multiple sclerosis relapse

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Vesicare and have Multiple sclerosis relapse.

Questions to the study

More questions >

User reviews to the study

More reviews >